Literature DB >> 26489162

Heart Failure.

Maheedhar Gedela, Muhammad Khan, Orvar Jonsson.   

Abstract

Heart failure is a major public health concern. It is the most common reason for hospitalization. It commonly affects older population and given the increasing life expectancy coupled with improved management of chronic medical conditions, the number of patients with heart failure is expected to increase. Heart failure has been recently categorized into heart failure with reduced and preserved ejection fraction. Despite differences in the two types, mortality remains high and similar in both conditions. Over the past few decades, numerous medical and device based therapies have been developed for the management of heart failure. These therapies have improved outcomes for the patients both in terms of morbidity and mortality. The objective of this review is to provide an overview of management of heart failure, specifically heart failure with reduced ejection fraction. It is of paramount importance for all health care providers to be aware of therapies for management of heart failure. We will also briefly discuss the role of mechanical circulatory support as an emerging new therapy for patients with advanced heart failure.

Entities:  

Mesh:

Year:  2015        PMID: 26489162

Source DB:  PubMed          Journal:  S D Med        ISSN: 0038-3317


  15 in total

1.  Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials.

Authors:  Yajie Xiang; Wenhai Shi; Zhuolin Li; Yunjing Yang; Stephen Yishu Wang; Rui Xiang; Panpan Feng; Li Wen; Wei Huang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

2.  Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure.

Authors:  Yu Zhang; Mingdan Zhu; Fugeng Zhang; Shaoqiang Zhang; Wuxun Du; Xuefeng Xiao
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

3.  Mortality Due to Heart Failure and Socioeconomic Development in Brazil between 1980 and 2018.

Authors:  Sonia Carvalho Santos; Paolo Blanco Villela; Gláucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

4.  SUV39H2/KMT1B Inhibits the cardiomyocyte senescence phenotype by down-regulating BTG2/PC3.

Authors:  Kan Wang; Qiang Zhang Zhu; Xian Tao Ma; Cai Cheng
Journal:  Aging (Albany NY)       Date:  2021-09-24       Impact factor: 5.682

5.  Mechanism of Zhen Wu Decoction in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking.

Authors:  Chen-Yu Ma; Yu-Qian Ma; Min Deng
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-15       Impact factor: 2.629

6.  Association of S100B 3'UTR polymorphism with risk of chronic heart failure in a Chinese Han population.

Authors:  Yuewu Chen; Xianghong Chen; Maozhong Yao; Lei Chen; Weiwei Chen; Xianxia Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

7.  DMPE-PEG scaffold binding with TGF-β1 receptor enhances cardiomyogenic differentiation of adipose-derived stem cells.

Authors:  Fei Zhang; Yuan Xie; Yuhao Bian
Journal:  Stem Cell Res Ther       Date:  2018-12-29       Impact factor: 6.832

8.  Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist Devices.

Authors:  Jeanine M Walenga; Tania A Torres; Walter P Jeske; Jeffrey Schwartz; Vicki Escalante; Joshua D Newman; Mamdouh Bakhos
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol.

Authors:  Rama Krishna Guggilla; Pawel Mateusz Sowa; Jacek Jamiolkowski; Siamala Sinnadurai; Adnan Amin; Karol Adam Kaminski
Journal:  Syst Rev       Date:  2020-08-24

Review 10.  Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review.

Authors:  Jasneet K Devgun; Samuel Kennedy; Jeremy Slivnick; Zachary Garrett; Katherine Dodd; Mohamed H Derbala; Cristina Ortiz; Sakima A Smith
Journal:  ESC Heart Fail       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.